CCG-100602
CCG-100602 inhibits RhoA/C-mediated, SRF-driven luciferase expression in PC-3 prostate cancer cells (IC50 :9.8 µM) .
Product Specifications
CAS Number
1207113-88-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
478.82
Molecular Formula
C21H17ClF6N2O2
Notes
Research use only, not for human use.
Receptor
Rho
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
123903-ML550 100 µL
BCR (Breakpoint Cluster Region Protein, Renal Carcinoma Antigen NY-REN-26, BCR1, D22S11) (MaxLight 550)
Ask
View Details